1. Home
  2. VC vs MESO Comparison

VC vs MESO Comparison

Compare VC & MESO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Visteon Corporation

VC

Visteon Corporation

HOLD

Current Price

$92.80

Market Cap

2.6B

ML Signal

HOLD

Logo Mesoblast Limited

MESO

Mesoblast Limited

HOLD

Current Price

$16.10

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VC
MESO
Founded
2000
2004
Country
United States
Australia
Employees
10000
81
Industry
Auto Parts:O.E.M.
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.2B
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
VC
MESO
Price
$92.80
$16.10
Analyst Decision
Buy
Strong Buy
Analyst Count
14
1
Target Price
$120.75
N/A
AVG Volume (30 Days)
433.7K
269.4K
Earning Date
04-23-2026
02-26-2026
Dividend Yield
1.61%
N/A
EPS Growth
N/A
N/A
EPS
7.28
N/A
Revenue
$3,768,000,000.00
N/A
Revenue This Year
$2.26
$644.56
Revenue Next Year
$5.19
$38.63
P/E Ratio
$12.78
N/A
Revenue Growth
N/A
N/A
52 Week Low
$69.88
$9.88
52 Week High
$128.32
$21.50

Technical Indicators

Market Signals
Indicator
VC
MESO
Relative Strength Index (RSI) 51.41 57.73
Support Level $89.31 $15.62
Resistance Level $106.35 $16.65
Average True Range (ATR) 3.06 0.53
MACD 0.48 0.20
Stochastic Oscillator 58.15 87.34

Price Performance

Historical Comparison
VC
MESO

About VC Visteon Corporation

Visteon Corp is an automotive supplier. It manufactures electronics products for original equipment vehicle manufacturers including Ford, Nissan, Renault, Mazda, BMW, General Motors, and Honda, etc. The company offers information displays, instrument clusters, head-up displays, infotainment systems, telematics solutions, and Smartcore. The Company's reportable segment is Electronics. The Electronics segment provides vehicle cockpit electronics products to customers, including digital instrument clusters, domain controllers with integrated driver assistance systems, displays, Android-based infotainment systems, and battery management systems. Geographically, it operates in North America, Europe, China, Asia-Pacific, and South America and Others.

About MESO Mesoblast Limited

Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The company's product candidates include: Ryoncil (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease, as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of an adult stem cell technology platform for commercialization.

Share on Social Networks: